{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:15:16Z","timestamp":1793499316115,"version":"4.5.0"},"reference-count":19,"publisher":"Wiley","issue":"S4","license":[{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To assess efficacy and safety of fixed\u2010ratio (1:1) combination insulin glargine and lixisenatide (iGlarLixi) compared to insulin glargine U100 (iGlar), with metformin, in Japanese patients with type 2 diabetes mellitus (T2DM) inadequately controlled on basal insulin and oral antidiabetic drugs (OADs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This 26\u2010week, randomized, open\u2010label study compared iGlarLixi to iGlar, both with metformin in adult Japanese patients with T2DM and hemoglobin (Hb) A1c \u22657.5% to \u22649.5%, treated with basal insulin and 1 or 2 OADs. Five hundred and twelve patients were randomized after a 12\u2010week run\u2010in, when iGlar was introduced and\/or further titrated and OADs other than metformin were stopped. The primary endpoint was change in HbA1c from baseline to week 26.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      iGlarLixi (n = 255) demonstrated significantly greater reductions in HbA1c (\u22121.27%) than iGlar (n = 257, \u22120.53%) (LS mean difference: \u20130.74%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u2009.0001) at week 26, confirming the superiority of iGlarLixi. Significantly, more iGlarLixi patients reached target HbA1c &lt;7% at week 26 (51.8% vs 16.0% for iGlar). iGlarLixi patients lost weight in contrast to iGlar patients (\u22120.51 kg vs +0.55\u2009kg). Documented symptomatic hypoglycemia (plasma glucose\u2009\u2264\u20093.9\u2009mmol\/L) was observed in 18.8% of iGlarLixi patients vs 16.7% of iGlar patients. iGlarLixi patients had more gastrointestinal\u2010related adverse events than iGlar patients (33.3% vs 8.6%), primarily nausea (16.9% vs 0.8%). However, the treatment was generally well\u2010tolerated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A once\u2010daily injection of iGlarLixi with metformin is an effective, well\u2010tolerated, and simple therapeutic intervention providing significant improvement in glycemic control in Japanese patients with T2DM inadequately controlled on basal insulin and up to two OADs.<\/jats:p>\n                    <jats:p>Clinical Trial Number: NCT02752412.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.14005","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T04:24:50Z","timestamp":1582086290000},"page":"3-13","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Efficacy and safety of insulin glargine\/lixisenatide fixed\u2010ratio combination (iGlarLixi) in Japanese patients with type 2 diabetes mellitus inadequately controlled on basal insulin and oral antidiabetic drugs: The LixiLan JP\u2010L randomized clinical trial"],"prefix":"10.1111","volume":"22","author":[{"given":"Hideaki","family":"Kaneto","sequence":"first","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism Kawasaki Medical School  Kurashiki Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akane","family":"Takami","sequence":"additional","affiliation":[{"name":"Research &amp; Development  Sanofi K.K., Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Spranger","sequence":"additional","affiliation":[{"name":"Diabetes, Cardiovascular and Metabolics Development Sanofi\u2010Aventis Deutschland GmbH  Frankfurt Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3698-6871","authenticated-orcid":false,"given":"Atsushi","family":"Amano","sequence":"additional","affiliation":[{"name":"Research &amp; Development  Sanofi K.K., Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Research &amp; Development  Sanofi K.K., Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Niemoeller","sequence":"additional","affiliation":[{"name":"Diabetes, Cardiovascular and Metabolics Development Sanofi\u2010Aventis Deutschland GmbH  Frankfurt Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,9,16]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0331"},{"key":"e_1_2_9_3_1","first-page":"a92267","article-title":"Efficacy and safety of 12\u2010month treatment with insulin glargine 300 U\/mL in insulin\u2010na\u00efve patients with type 2 diabetes: XSTAR study subanalysis (JDS abstract)","volume":"62","author":"Odawara M","year":"2019","journal-title":"J Japan Diabetic Soc"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-S009"},{"key":"e_1_2_9_5_1","first-page":"28","volume-title":"Treatment Guide for Diabetes 2018\u20132019","author":"The Japan Diabetes Society","year":"2018"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4729-5"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2647"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1495"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(02)00177-8"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2827-3"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12293"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12490"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13757"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0917"},{"key":"e_1_2_9_15_1","first-page":"a92515","article-title":"Efficacy and safety of 26\u2010week of insulin glargine\/lixisenatide fixed ratio combination in Japanese patients with type 2 diabetes mellitus: comparison with insulin glargine monotherapy (JDS abstract)","volume":"62","author":"Terauchi Y","year":"2019","journal-title":"J Japan Diabetic Soc"},{"key":"e_1_2_9_16_1","first-page":"a92366","article-title":"Efficacy at week 26 and safety at week 52 of insulin glargine\/lixisenatide fixed ratio combination in Japanese patients with type 2 diabetes mellitus: comparison with lixisenatide monotherapy (JDS abstract)","volume":"62","author":"Takami A","year":"2019","journal-title":"J Japan Diabetic Soc"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci18-0018"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12331"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2008.01.003"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13462"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdom.14005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.14005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.14005","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.14005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:03:03Z","timestamp":1761861783000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.14005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":19,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1111\/dom.14005"],"URL":"https:\/\/doi.org\/10.1111\/dom.14005","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.14005\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14005\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14005\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14005\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14005\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.14005\/v2\/review1","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"2019-12-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}